This episode takes a deep dive into the advanced statistical methods employed in Phase 3 clinical trials, examining the concepts of statistical power and significance. We explore the factors that determine a trial's power, including sample size, treatment effect size, and data variability, and how these factors are intertwined in the sample size calculation process. We discuss the role of randomization and how it helps to minimize bias by ensuring balanced treatment groups. The concept of the significance threshold and its role in determining if the observed treatment effects are real or just due to chance is also explored. Join us as we unpack the statistical framework that underpins the analysis and interpretation of data in these pivotal trials.

We further explore the intricacies of data analysis in Phase 3 trials, discussing various sta ...